ALT vs BB · rev $20.0K vs P/E 117, rev $549.1M
Altimmune Inc (ALT) versus BlackBerry Ltd (BB) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
ALT currently screens at market cap $527.0M. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Not investment advice. Open the ALT and BB stock pages for the full models.
Not investment advice.